Dr. Daniel Southworth is a Professor in the Department of Biochemistry and Biophysics at the University of California San Francisco (UCSF), affiliated with the Institute for Neurodegenerative Diseases (IND). He earned his BS from UC Santa Cruz and PhD from Johns Hopkins University, followed by postdoctoral training at UCSF. His research focuses on molecular chaperones and protein quality control mechanisms relevant to neurodegenerative diseases like Alzheimer’s and Parkinson’s. Using cryo-electron microscopy (cryo-EM), his lab investigates chaperone machinery structure-function relationships, amyloid aggregation pathways, and therapeutic strategies targeting molecular chaperones. Key research areas include: (1) Structural biology of chaperones like Hsp90, CHIP, and Hsp104; (2) Mechanisms of tau and α-synuclein aggregation; and (3) Development of cryo-EM techniques for studying protein complexes. Recent work has revealed novel filament structures in neurodegenerative diseases and identified polyphosphate’s role in amyloid formation. His lab pioneered studies on VCP/p97 AAA+ ATPases and their adaptors, elucidating their roles in protein quality control. Collaborations include CRISPR-based screening in iPSC-derived neurons and drug design targeting chaperone-driven proteostasis. Notable contributions include cryo-EM structural analysis of SARS-CoV-2 proteins and methodological advancements in cryo-EM imaging using K3 cameras. Current research emphasizes translating structural insights into therapeutic approaches for neurodegenerative disorders.
Tore B. Stage is a Professor and Research Leader at the Institute for Health Services Research (Clinical Pharmacology, Pharmacy and Environmental Medicine) at the University of Southern Denmark. His research focuses on individual variability in drug response, particularly drug interactions and pharmacogenetics, utilizing both in vitro models and clinical trials. Primary research areas: Pharmacogenetics Chemotherapy-Induced Peripheral Neuropathy Pharmacokinetic Modeling Drug Transport Mechanisms Key publications include mechanistic studies of neurotoxicity in cancer patients and translational models bridging in vitro and clinical findings. His work spans immunosuppressants, anticoagulants, and chemotherapeutic agents. Major scientific awards: Lundbeckfondens Talentpris (2017) DFF-Research Talent (2015) ISSX Poster Award (2017) Presidential Trainee Award (2016) Jason Morrow Trainee Award (2016) He supervises PhD students, including Mortensen, C. (2020-2022), on projects exploring chemotherapy-induced neuropathy mechanisms.
Professor Wei Wei is a distinguished researcher in the Department of Neurobiology at the University of Chicago, where he leads a lab focused on understanding the synaptic basis of neural computation in the retina. His work bridges cellular and systems neuroscience, with particular emphasis on how retinal circuits process visual information to detect motion and other visual features. Institution: University of Chicago Department: Neurobiology Research Focus: Retinal circuitry and visual processing Current Funding: Multiple NIH R01 grants Dr. Wei received his PhD in Neurobiology from Cold Spring Harbor Laboratory in 2008, followed by postdoctoral training at the University of California, Berkeley from 2008-2011. His educational background provided him with a strong foundation in both molecular/cellular neuroscience and systems-level approaches to neural circuit function. Wei's research primarily investigates how neural circuits in the retina are assembled to perform specific computations, with particular focus on motion detection. His lab leverages genetic tools that label specific retinal neuron types to target synapses of interest, using multiphoton microscopy, visual stimulation, electrophysiology, and molecular biology to characterize synaptic maturation and function. A key area of investigation involves starburst amacrine cells and their role in direction selectivity. His work has revealed how dendritic computations, synaptic plasticity, and circuit organization contribute to visual processing. Analysis of Wei's recent publications shows a clear progression from fundamental circuit mechanisms toward understanding more complex visual processing in naturalistic contexts. His work spans from cellular and synaptic physiology to systems-level circuit function, with a consistent focus on motion detection mechanisms. The research increasingly incorporates advanced imaging techniques and computational approaches to understand how retinal circuits transform visual inputs into neural representations. 2012 Whitehall Foundation Grant 2013 Sloan Research Fellowship 2013 E. Matilda Ziegler Foundation Grant 2014 Karl Kirchgessner Foundation Grant 2016 McKnight Scholar Award As Principal Investigator on multiple NIH R01 grants totaling millions of dollars, Wei directs a well-funded research program investigating the synaptic basis of motion detection in the retina. His current projects explore dynamic interactions between synaptic and intrinsic properties of starburst amacrine cells, circuit mechanisms for encoding naturalistic motion, and the developmental basis of motion detection circuits. The lab maintains strong collaborations with other researchers in visual neuroscience, as evidenced by co-authorship with scientists at multiple institutions. The Wei Lab operates within the University of Chicago's Department of Neurobiology, utilizing state-of-the-art facilities for retinal imaging and electrophysiology. The lab employs a multidisciplinary approach that combines genetic, optical, electrophysiological, and computational techniques to dissect retinal circuit function. Current research directions include investigating how short-term plasticity shapes circuit function, how dendritic computations contribute to visual processing, and how retinal circuits adapt to changing visual environments.
Julie Miwa serves as an Associate Professor in the Department of Biological Sciences within the College of Arts and Sciences at Lehigh University. Her research laboratory investigates complex neurobiological processes with a specific focus on the cholinergic system and its regulation through lynx genes. Dr. Miwa's work employs a highly multidisciplinary approach that combines molecular genetics, genetic engineering, electrophysiology, behavioral analysis, and biochemical techniques. Dr. Miwa's research centers on lynx proteins, which function as molecular brakes on nicotinic acetylcholine receptors. Her laboratory generates genetically engineered mouse lines to characterize how these regulatory proteins influence neural function and behavior. Key findings from her research demonstrate that manipulating lynx proteins affects learning capabilities, critical period plasticity, anxiety responses, and neuronal survival. Her work has significant implications for understanding neural adaptation mechanisms and potential therapeutic approaches for neurological conditions. Analysis of Dr. Miwa's publication record reveals a consistent trajectory of research focused on cholinergic regulation, with particular emphasis on lynx proteins and their interactions with nicotinic receptors. Her work spans molecular mechanisms, cellular function, and behavioral outcomes, demonstrating a comprehensive approach to neuroscience research. The publications show increasing sophistication in techniques and expanding applications to understanding neural plasticity, learning mechanisms, and potential relevance to neurological disorders. Dr. Miwa's laboratory actively seeks researchers with expertise in molecular genetics, genetic engineering, behavioral pharmacology, and biochemical techniques. Her research program appears to be well-established with consistent publication output across nearly two decades, indicating sustained funding and productive research operations. While specific grant information isn't provided in the available text, the longevity and productivity of her research program suggest successful grant acquisition and management. The laboratory focuses on investigating how lynx proteins regulate the cholinergic system through multidisciplinary approaches. Current research directions include examining the role of lynx proteins in motor learning, anxiety-related behaviors, and neuronal health during aging. The lab utilizes genetically engineered mouse models combined with electrophysiological, behavioral, biochemical, and microscopic techniques to unravel the complex relationships between molecular regulation and behavioral outcomes.
Julian Antonio Martinez-Agosto is an Associate Professor at the UCLA School of Medicine with appointments in the Department of Human Genetics, Pediatrics, and Psychiatry and Biobehavioral Sciences. Board-certified in Medical Genetics, he has served on the UCLA faculty since 2007 after completing his MD/PhD at Yale University and pediatric training at Mattel Children's Hospital UCLA. His research focuses on novel growth regulatory pathways in progenitor and stem cell maintenance, particularly studying human growth disorders with cancer predisposition. Yale University: MD/PhD in Medicine/Neuroscience (2000) UCLA: Pediatric Residency and Medical Genetics Training Postdoctoral Fellow: Laboratory of Utpal Banerjee at UCLA Dr. Martinez-Agosto's research spans genetics, developmental biology, and neurogenetics with specific emphasis on overgrowth disorders, cancer predisposition syndromes, and autism spectrum disorders. His laboratory investigates molecular pathways including PTEN, mTOR, and other growth regulatory mechanisms using both human clinical studies and Drosophila models. His clinical practice focuses on genetic syndromes leading to overgrowth, vascular malformations, and cancer predisposition. His recent publications reveal strong trends in autism genomics, PTEN-related disorders, neurodevelopmental conditions, and molecular mechanisms of growth regulation. The research demonstrates interdisciplinary collaboration across genetics, neurology, and pediatrics with emphasis on translational applications. Cell Press 2021 Faces of Cell Pediatric Department Outstanding Research Award David W. Smith Pediatric Trainee Research Award Dr. Martinez-Agosto serves as Principal or Co-Principal Investigator on multiple NIH-funded research projects including studies on PTEN-associated autism, undiagnosed disorders, and Drosophila hematopoietic stem cell niches. His laboratory has trained numerous researchers in the field of medical genetics and developmental biology. His research is conducted through the Martinez Lab, which maintains active collaborations with multiple research groups at UCLA and other institutions, focusing on translational approaches to understanding genetic growth disorders.
Peter C. Petersen is an Associate Professor in the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen. Holding a Civilingeniør (MSc) in Technical Physics from DTU and a PhD in Neuroscience, he specializes in systems-level neural mechanisms using electrophysiological approaches. His educational background includes: Civilingeniør (MSc) in Technical Physics, DTU PhD in Neuroscience Petersen's research focuses on neural dynamics in memory and motor systems, combining in vivo electrophysiology with computational modeling. He investigates hippocampal place cells for spatial working memory and rotational dynamics in spinal cord networks, while developing neurotechnology tools like CellExplorer for single-neuron analysis. His work bridges experimental neuroscience, engineering, and data science to decode circuit-level computations. Recent publications (2020-2024) reveal a dual emphasis on hippocampal memory mechanisms (e.g., temperature effects on sharp wave ripples) and innovative methodology (e.g., 3D-printed microdrives). This trajectory demonstrates consistent advancement from tool development to fundamental discoveries in neural coding, with increasing collaboration intensity as evidenced by multi-institutional authorship. Scientific awards: No specific awards were documented in the source material. While explicit advising details are absent, his leadership in software/hardware development (CellExplorer, microdrive systems) implies active mentorship of technical researchers. Grant information isn't specified, though high-impact publications suggest sustained funding for neurotechnology and systems neuroscience projects. Petersen directs the Petersen Lab (https://petersenlab.org/), which employs chronic electrophysiology in rodent models to study memory and movement. The lab maintains strong ties with the Buzsáki lab (hippocampal research) and continues collaborations initiated during his NYU Langone Health tenure (2016-2022), reflecting an integrated approach to neural circuit analysis across institutions.
Mark Monroe Rich is a Professor in the Department of Neuroscience, Cell Biology & Physiology and Professor of Clinical Neuroscience at Wright State University School of Medicine, with over 25 years of combined clinical and research expertise in neuromuscular diseases. His MD/PhD background includes specialized fellowship training in neuromuscular disorders, positioning him at the intersection of patient care and laboratory investigation. Dr. Rich's research program centers on electrophysiologic defects across the neuromuscular axis, with particular emphasis on peripheral nerve pathologies, neuromuscular junction dysfunction, and skeletal muscle excitability disorders. His lab actively investigates disease mechanisms in myasthenia gravis, Lambert-Eaton syndrome, critical illness neuropathies, spinal muscular atrophy, ALS, Huntington's disease-related myopathies, and chemotherapy-induced sensory deficits. Current work focuses on identifying druggable targets for rapid therapeutic translation, especially regarding muscle excitability dysregulation in genetic muscle diseases. Analysis of his 15 most recent publications reveals a consistent trajectory toward mechanistic studies of action potential abnormalities in disease models, with growing emphasis on Huntington's disease, myotonia congenita, and periodic paralysis. His work increasingly integrates transverse tubule ultrastructure, ion channel dysfunction, and neuromuscular junction plasticity to explain pathological phenotypes. Dr. Rich's contributions have been recognized through significant honors: Wright State Academy of Medicine Outstanding Senior Faculty Achievement Award (2019) University Professor designation (2019) Teaching excellence award, School of Medicine (2020 and 2022) His laboratory maintains continuous NIH funding exceeding 25 years, supporting both basic science investigations and therapeutic development. While specific student mentorship isn't detailed in available records, his extensive publication record (110+ articles) indicates active training of researchers through collaborative projects. The lab employs advanced electrophysiological and ex vivo preparation techniques to model disease states and evaluate potential interventions, operating within Wright State's neuroscience research infrastructure.
Ryoma Hattori is an Assistant Professor at the University of Florida, based at the UF Scripps Biomedical Research campus in Jupiter, FL. His laboratory, the Hattori Lab, focuses on neural mechanisms underlying cognitive functions, learning, and their disruption in autism. Dr. Hattori received his educational degrees from prestigious institutions: Ph.D. in Molecular and Cellular Biology from Harvard University (2016) A.M. in Molecular and Cellular Biology from Harvard University (2012) B.S. in Biophysics and Biochemistry from the University of Tokyo (2010) His research interests center on decision making, reinforcement learning, and number sense, using systems and computational approaches. The lab employs techniques such as in vivo 2-photon imaging, optogenetics, virtual reality behaviors, and machine learning to investigate neural activity and plasticity dynamics in mice. A significant focus is understanding how these processes are impaired in autism spectrum disorder. Analysis of his recent publications reveals a strong emphasis on computational neuroscience and neural circuit mechanisms. His work spans from developing advanced imaging and analysis tools to uncovering fundamental principles of value coding and meta-reinforcement learning, with applications in both basic neuroscience and artificial intelligence. Dr. Hattori has received numerous scientific awards, including: Outstanding Mentor Award 2025 from Society of Research Fellows, UF Scripps SFARI Bridge-to-Independence Award 2022-Current from Simons Foundation Warren Alpert Distinguished Scholar Award 2021-2024 from Warren Alpert Foundation Postdoctoral Grant Award 2021-2022 from The KANAE Foundation And several fellowships during his postdoctoral and graduate training. As a principal investigator, Dr. Hattori leads multiple active grants, including the Shenoy Undergraduate Research Fellowship in Neuroscience (2025-2026) and a project on "Neural activity and plasticity dynamics for reinforcement learning in autism" funded by the Simons Foundation. His mentorship has been recognized with the Outstanding Mentor Award. The Hattori Lab is a dynamic research group utilizing cutting-edge technologies to explore the neural basis of cognition, with a particular interest in translational implications for autism and related disorders.
Sarah A Stanley, MBBCh, PhD is a faculty member at the Icahn School of Medicine at Mount Sinai, where she leads the Stanley Laboratory. Her research spans multiple disciplines at the intersection of neuroscience, diabetes, and molecular biology, with significant contributions to understanding the neuroendocrine regulation of metabolism. Education: BA, University of Cambridge BChir, University of Cambridge MB, University of Cambridge PhD, Imperial College, London University Dr. Stanley's research focuses on three primary areas: pioneering the use of radio waves and magnetic fields to stimulate individual cells and neurons (radiogenetics and magnetogenetics); developing nanoparticles in bioengineered murine models for preclinical applications; and advancing understanding of the interaction between central and peripheral systems in appetite control and diabetes. Her work represents a unique integration of engineering approaches with fundamental neuroscience and metabolic research. Her publications demonstrate a strong trajectory in neuroendocrine research with applications to diabetes treatment, showing increasing sophistication in techniques from molecular biology to advanced neural modulation approaches. The research shows particular strength in translating basic science discoveries into potential therapeutic applications. Scientific Awards: 2016 Alexander and Alexandrine Sinsheimer Scholar Award 2016 Dr. Harold and Golden Lamport Research Award 2015 Cell Symposia: Engineering the Brain International Travel Award Darwin Prize in Experimental Natural Sciences Arthur Burrows Prize (Dermatology) James Anderson Prize (Medicine and Surgery) Dr. Stanley's laboratory is currently funded by The National Institutes of Health and American Diabetes Association, working in close collaboration with colleagues across Mount Sinai and partnerships with Professor Jeffrey Friedman at Rockefeller University and Professor Jonathan Dordick at Rensselaer Polytechnic Institute. Her research program demonstrates strong institutional support and strategic collaborations that enhance the impact of her work. The Stanley Laboratory operates across multiple facilities at Mount Sinai, including locations in the Annenberg Building and Atran Berg Laboratory Building, reflecting the interdisciplinary nature of her research that bridges neuroscience, engineering, and metabolic medicine.
Jesse R. Dixon, M.D., Ph.D., is an Associate Professor at the Gene Expression Laboratory of the Salk Institute for Biological Studies in La Jolla, California. His research explores 3D genome architecture, chromatin organization, and gene regulation mechanisms, with implications for cancer and developmental disorders. He employs cutting-edge genomic technologies like Hi-C and single-cell multi-omics to investigate how chromosomal rearrangements impact gene expression. Dr. Dixon's work focuses on: Topological Domains (TADs) and their role in enhancer-promoter communication Haplotype phasing using chromatin conformation data Structural variant-driven oncogene activation in cancer Single-cell mapping of chromatin and DNA methylation dynamics His publications consistently demonstrate innovations in 3D genome analysis, particularly in neurobiology and oncology contexts, with recurring themes of chromatin topology, epigenetic regulation, and computational genomics. Awards & Honors: Pew Biomedical Scholar (2024) Helmsley Salk Fellow He mentors graduate and postdoctoral researchers in genomics and computational biology, with current projects on chromatin dynamics in cancer and development. The Dixon Lab actively develops novel methodologies for studying genome architecture.
Dr. Adele McCormick is Reader in Molecular Virology at the University of Westminster's School of Life Sciences, where she leads the Genomics and Infectious Diseases research group. She coordinates the MSc Biomedical Science program and teaches molecular biology and clinical microbiology. Education background: PhD in Sustainable Energy Systems, University of Sheffield MSc in Clinical Pathology, University of Sheffield BSc in Biochemistry and Microbiology, University of Sheffield Her research focuses on viral pathogenesis, antiviral resistance mechanisms in HIV/HCV, and the role of endogenous retroviruses in neurological disorders. She established the university's genomics facility for BSL-2 pathogen sequencing and collaborates internationally on antiviral development projects. Recent publications emphasize molecular diagnostics, SARS-CoV-2 therapeutics, and retroviral involvement in ALS. Her work shows increasing focus on nanoparticulate antivirals and long-read sequencing applications since 2020. Dr. McCormick has secured substantial research funding including an ALS Association grant ($325,000) and directs the Westminster virology research group. She is a Fellow of the Royal Society of Biology and serves on editorial boards for virology journals.
Terry D. Johnson is Senior Instructional Professor and Program Director for the Master of Engineering at the University of Chicago's Pritzker School of Molecular Engineering. He holds an MS in Chemical Engineering from MIT and is an emeritus Teaching Professor from UC Berkeley, where he co-founded the Masters of Translational Medicine program. Research integrates engineering and biomedicine, with patented innovations in tissue engineering and synthetic biology. Recent work develops sustainable textile dyeing technologies eliminating toxic reductants. Earlier projects include microfluidic hepatocyte cultures and EGF-functionalized biomaterials. Awards: Golden Apple Award for Outstanding Teaching (UC Berkeley 2010) Distinguished Teaching Award (UC Berkeley 2013) Co-authored the popular science book How to Defeat Your Own Clone . Teaches molecular engineering courses and directs master's programs bridging technical innovation and medical translation.
Thomas Carell is a Professor of Organic Chemistry at the Faculty of Chemistry and Pharmacy, Ludwig Maximilian University of Munich, Germany, a position he has held since 2003. He has established himself as a leading researcher in the fields of epigenetics, DNA repair mechanisms, and prebiotic chemistry. His work bridges chemistry and biology, with significant contributions to understanding epigenetic modifications and the origins of life. Dr. Carell's educational background includes chemistry studies at Münster and Heidelberg Universities, where he completed his PhD under Professor Staab. He then pursued postdoctoral research at MIT with Professor J. Rebek, focusing on chemical compound libraries and projects bridging chemistry and biomedicine. Professor Carell's research interests center on the chemical analysis of epigenetic modifications and processes, particularly focusing on DNA/RNA lesion processes using nucleotide analogues, tracers, and high-end mass spectrometry. His laboratory has made groundbreaking contributions to understanding prebiotic chemistry and the origins of life, developing innovative technologies for non-canonical nucleoside and nucleotide synthesis. A significant portion of his work explores the organic chemistry of modified nucleosides and nucleotides, with implications for understanding fundamental biological processes and potential therapeutic applications. His research has evolved from early work on nucleic acid chemistry at ETH Zurich to pioneering studies on photolyase reactions and DNA repair at Marburg, culminating in his current work on epigenetic control mechanisms and prebiotic chemistry at LMU Munich. His extensive publication record demonstrates a consistent trajectory of high-impact research, with articles appearing in top-tier journals including Nature, Science, and Cell. The research themes span from fundamental organic chemistry to biological applications, with a particular emphasis on epigenetic mechanisms and prebiotic chemistry. His most recent work suggests an early RNA-peptide world, potentially revolutionizing our understanding of life's origins, building on his earlier discoveries regarding DNA lesion-induced mutations, DNA repair mechanisms, and epigenetic control via oxidative DNA methylation. Professor Carell's scientific achievements have been recognized with numerous prestigious awards: Supervisory Board member of BASF SE (2019) Alexander Todd-Hans Krebs Lectureship, Royal Society of Chemistry (2017) Windaus Memorial Lecture, Göttingen (2017) Inhoffen-Medal for Excellence in Natural Product Research of the Helmholtz Society (2016) Gait-Lecture Award, Royal Society of Chemistry (2014) Werdelmann Lecture, University-Essen Duisburg (2013) Melvin Calvin Lecture in Organic Chemistry, University of California, Berkeley (2011) Šorm Award of the Academy of Sciences of the Czech Republic (2011) Order of Merit from the Federal Republic of Germany (2010) Van 't Hoff Lecture, Royal Dutch Academy of Sciences (2009) Ferdinand Lecture, University of Sheffield (2008) Otto Bayer Award, Bayer Schering Foundation (2008) Philip Morris Research Award (2006) Gottfried Wilhelm Leibniz Award of the DFG (2004) Lady Davis Award, Technion, Israel (2004) Pasteur Medal of the JCO, Ecole Polytechnique (2001) Professor Carell leads an active research group (the Carell Group) at LMU Munich, supervising numerous PhD and Master's students working at the intersection of chemistry and biology. His laboratory has secured significant research funding to support their innovative work on epigenetic modifications, DNA repair mechanisms, and prebiotic chemistry. The group maintains strong international collaborations, as evidenced by Professor Carell's numerous visiting professorships at institutions worldwide, including University Descartes in Paris, Australian National University, Consiglio Nazionale delle Ricerche in Bologna, and Technion Israel Institute of Technology. The Carell laboratory operates state-of-the-art facilities for organic synthesis, mass spectrometry, and molecular biology, enabling their interdisciplinary research approach. The group consists of chemists, biochemists, and molecular biologists working collaboratively to address fundamental questions in chemical biology. Professor Carell's election to the Supervisory Board of BASF SE in 2019 highlights the translational impact of his research and his standing in both academic and industrial chemistry communities.
Lena Nguyen is an Assistant Professor at the University of Texas at Dallas (UTD) within the School of Behavioral and Brain Sciences. Her research focuses on understanding the neurobiological mechanisms of brain development and how molecular signaling pathways contribute to neurodevelopmental disorders and epilepsy. She leads the Neurodevelopmental Disorders and Epilepsy Lab, aiming to advance treatments for conditions like tuberous sclerosis complex and focal cortical dysplasia. Nguyen holds a B.S. in Biology (University of Houston, 2009), a Ph.D. in Neuroscience (Baylor College of Medicine, 2016), and completed postdoctoral training in Neurosurgery and Cellular & Molecular Physiology at Yale University School of Medicine (2022). Her work integrates molecular biology, animal models, and translational approaches to study mTOR signaling pathways and their role in epilepsy pathogenesis. Key research interests include cortical neuron development, molecular mechanisms of epilepsy, and translational control. Her studies investigate how dysregulation of pathways like mTORC1 and 4E-BP1 leads to neuronal dysfunction and seizures, with a focus on developing therapeutic strategies. Recent work highlights the potential of targeting MEK-ERK signaling and HCN4 channels in epilepsy treatment. Nguyen has received prestigious awards including the American Epilepsy Society Fellows Program (2019), the Epilepsia Basic Science Prize (2016), and the Grass Foundation Young Investigator Award (2014). Her funding includes grants from the TSC Alliance, NIH-NICHD, and the Yale Swebilius Foundation, supporting projects on translational control mechanisms, gene therapy, and developmental epilepsy. Her lab actively explores novel therapeutic targets and employs cutting-edge techniques such as in utero electroporation and translating ribosome affinity purification to study age-dependent gene expression in cortical neurons. Ongoing projects aim to bridge basic research with clinical applications, focusing on improving outcomes for patients with neurodevelopmental and epileptic disorders.
Massimo Filippi is a Full Professor of Neurology at Vita-Salute San Raffaele University and holds leadership roles including Director of the Neurology and Neurorehabilitation Units, Multiple Sclerosis Center, Alzheimer Center, and Quantitative Neuroimaging Unit at San Raffaele Hospital. His research focuses on neuroimaging techniques, particularly MRI, to study neurological diseases like multiple sclerosis and Alzheimer’s. He has authored over 1,640 papers and serves on editorial boards of major journals, including co-editing the Journal of Neurology. Education: MD from University of Milan (1986) Specialization in Neurology (University of Milan, 1990) Specialization in Neurophysiopathology (University of Pavia, 1994) Research Interests: Pioneering the use of MRI to understand disease mechanisms in multiple sclerosis, neurodegenerative disorders, and brain mapping. His work emphasizes clinical neuroimaging biomarkers, disease progression, and therapeutic monitoring. Key Awards: Rita Levi Montalcini Award (2001) Distinguished Dr. Luis Barraquer Ferré Lecture (2015) Ranked #1 in global MS research influence (2022) Teaching & Leadership: Oversees neurology residency programs, chairs academic committees, and advises international institutions. He has held over 680 invited lectures and chairs major congresses like AAN and ECTRIMS. Labs/Teams: Heads the Neurotech Hub, Neuroimaging Research Unit, and the BrainMap interdepartmental program, integrating advanced neuroimaging with clinical research.
